Introduction
The c-Myc oncoprotein, in addition to its role in transformation (Classen and Hann, 1999) in¯uences other cellular processes including growth, proliferation, cell cycle progression, dierentiation, apoptosis, and genomic stability (Coppola and Cole, 1986; Prochownik and Kukowska, 1986; Prochownik et al., 1988; Iritani and Eisenman, 1999; Obaya et al., 1999; Prendergast, 1999; Schmidt, 1999; Yin et al., 1999b) . All of the known biological functions of c-Myc require an intact transcriptional activation domain (TAD), comprising the ®rst 150 amino acids of the protein (Stone et al., 1987; Kato et al., 1990; Evan et al., 1992; Amati et al., 1993a,b) . Also required is a bHLH-ZIPtype DNA binding and dimerization domain located at the extreme carboxy-terminus of the protein (Smith et al., 1990; LuÈ scher and Larsson, 1999) .
Transcriptional activation occurs when c-Myc, in association with its obligate bHLH-ZIP heterodimerization partner Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) , binds to a target gene containing a consensus E-box motif of the sequence CAC/TGTG (Blackwood et al., 1990 (Blackwood et al., , 1993 . Several putative E-box-containing genes such as ODC, LDH-A, and CAD have been shown to be activated by cMyc (Classen and Hann, 1999; Dang, 1999) . c-Myc can also repress the transcription of certain genes, including itself, gadd45 and p21 CIP1 through less well de®ned, Ebox-independent, mechanisms (Facchini and Penn, 1998; Hann, 1999, 2000) .
Originally identi®ed through its association with cMyc, Max has emerged as the central member of a protein network that regulates Myc target gene expression (Henriksson and LuÈ scher, 1996) . At least four additional, and related, Max-interacting bHLH-ZIP proteins, Mad1, Mxi1, Mad3, and Mad4 (the Mad family') oppose the positive eects of c-Myc on E-boxdirected transcriptional activation (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995a,b) . This occurs through mechanisms which include competition with cMyc for Max heterodimerization and E-box occupancy, and the recruitment by Mad-Max heterodimers of a protein complex that actively promotes histone deacetylation and transcriptional repression (Ayer et al., 1995; Schreiber-Agus et al., 1995; Alland et al., 1997; Laherty et al., 1997) . Myc and Mad proteins tend to be oppositely regulated during the course of terminal dierentiation (Hurlin et al., 1994 (Hurlin et al., , 1995b . More recently, Mnt, a bHLH-ZIP protein unrelated to the Mad family, has been shown to heterodimerize with Max and mediate transcriptional repression through a mechanism similar to that utilized by Mad proteins (Hurlin et al., 1997) .
Using a yeast two-hybrid approach with Mad1 as a bait, we previously cloned and characterized a nonbHLH-ZIP protein, Mmip-2/Rnf-17 that interacts with all four Mad members but not with c-Myc, Max or with the bHLH proteins MyoD or Id1 (Yin et al., 1999a) . Mmip-2/Rnf-17 contains a consensus RING ®nger domain, only a portion of which, along with an additional region at the extreme carboxy-terminus, is required for its interaction with Mad proteins. The association also requires an intact ZIP domain of the Mad partner protein but not its bHLH domain. The major consequence of the Mmip-2/Rnf-17-Mad interaction is to disrupt Mad-Max complexes, thus allowing for the re-formation of c-Myc-Max heterodimers and a restoration of c-Myc function. Interestingly, Mmip-2/ Rnf-17 may localize either to the cytoplasm or nucleus depending upon the relative abundance of co-expressed Mad protein. When Mmip-2/Rnf-17 is in excess, it localizes to the cytoplasm in large, juxtanuclear`dots' (2 ± 5/cell) which sequester Mad proteins. In contrast, relative Mad excess results in a translocation and redistribution of Mmip-2/Rnf-17 from the cytoplasm to the nucleus where it assumes a diusely speckled pattern and co-localizes with Mad.
A number of c-Myc-gene targets have been identi®ed by a variety of techniques (Dang, 1999; Coller et al., 2000; O'Hagan et al., 2000) . Using cDNA microarrays, we have recently characterized additional such targets in the 32D murine myeloid cell line (Nesbit et al., 2000) . In the current study, we have determined that the redistribution of Mad proteins, mediated by Mmip-2/Rnf-17, enhances the sensitivity of cells to several apoptotic stimuli in much the same way as does c-Myc overexpression. Several c-Myc-regulated target genes are also regulated in response to Mmip-2/Rnf-17. Unexpectedly, we have observed that some of these are also modulated by glucocorticoid hormones (GCs). Our ®ndings strengthen the notion that Mmip-2/Rnf-17 serves as an indirect, positive regulator of c-Myc activity. In addition, they point to a previously unrecognized relationship between genes regulated by c-Myc and GCs.
Results

Conditional expression of Mmip-2/Rnf-17 in 32D cells
In order to study the eects of Mmip-2/Rnf-17 on 32D cells, we expressed the protein with a carboxy-terminal c-Myc epitope tag and under the control of the glucocorticoid-inducible MMTV promoter (Sklar et al., 1991) . Stably transfected cells (Mmip-2/Rnf-17 cells) were obtained after electroporation of linearized plasmid DNA followed by selection in G-418. A control cell line, referred to as`neo' was obtained by pooling G-418-resistant clones following electroporation with the empty pMSG-MTneo vector. Pooled G-418-resistant cells as well as two clones, obtained by limiting dilution, were examined for the expression of Mmip-2/Rnf-17 either prior to or following exposure to 10 77 M dexamethasone (DX) for varying lengths of time (Figure 1 ). In all three cases, signi®cant upregulation of Mmip-2/Rnf-17 protein expression was seen within 4 h of DX addition. Expression was also seen in the absence of DX, thus indicating substantial leakiness' of the MMTV promoter in 32D cells. Of more than 20 clones examined, all showed DXinducible expression of Mmip-2/Rnf-17 as well as varying levels of constitutive expression (not shown).
Expression of Mmip-2/Rnf-17 results in a subcellular re-distribution of Mad proteins Using dierent isoforms of green¯uorescent protein (GFP) fused to Mad3 or Mmip-2/Rnf-17, we have previously shown in transient transfection experiments that the former protein is distributed in a diuse speckled pattern throughout the nucleus, whereas Mmip-2/Rnf-17 is con®ned to a small number (2 ± 5/ cell) of large perinuclear`dots' (Yin et al., 1999a) . When Mmip-2/Rnf-17 is co-expressed in molar excess to Mad3, however, the latter undergoes a subcellular redistribution and co-localizes with Mmip-2/Rnf-17 in the cytoplasm. In order to con®rm this with another Mad family member, as well as under conditions of stable expression with non-GFP-tagged proteins, pooled neo and Mmip-2/Rnf-17 cells were grown in the absence of DX for 48 h and were then fractionated into nuclear and cytoplasmic components. Equivalent amounts of each extract were then resolved by SDS ± PAGE, blotted, and probed with antibodies against c-Myc, Max, c-Myc-epitope-tagged Mmip-2/Rnf-17, and Mxi1, the most abundantly expressed member of the Mad family in 32D cells (unpublished observations and see below). As seen in Figure 2 , c-Myc and Max were 77 M) was then added for the indicated periods of time at which point the cells were harvested and prepared for Western analysis. The upper half of the blot was used to detect Mmip-2/ Rnf-17 using the 9E10 c-Myc epitope monoclonal antibody. The lower half of the blot was used to detect b-actin as a control for protein loading con®ned almost exclusively to the nuclear compartment in both neo and Mmip-2/Rnf-17 cells. Consistent with our previous results (Yin et al., 1999a) , Mmip-2/Rnf-17 expression was primarily cytoplasmic. Of greatest interest was that Mxi1 was con®ned almost exclusively to the nucleus in neo cells, whereas in Mmip-2/Rnf-17 cells, it was primarily cytoplasmic. Similar results were seen in cl 15 cells (not shown). The addition of DX to the cells for 48 h increased only slightly the amount of Mxi1 that was redistributed to the cytoplasm (not shown). In additional control experiments designed to test the relative purity of each fraction, we detected poly (ADP-ribose) polymerase (PARP) only in the nuclear fractions and Bcl-2 only in the cytoplasmic fractions of both cell lines Taken together, these observations con®rm our previous observations that relative overexpression of Mmip-2/Rnf-17 results in a selective translocation of Mad family members from their normal nuclear compartment to a cytoplasmic one.
Expression of some Myc network transcripts is perturbed in cells which overexpress Mmip-2/Rnf-17
The translocation of Mad proteins from the nucleus to the cytoplasm in the presence of co-expressed Mmip-2/ Rnf-17 results in a loss of transcriptional repression, thus creating a functional`Mad null' phenotype. Consequently, a restoration or enhancement of endogenous c-Myc transcriptional function is observed (Yin et al., 1999a) . This presumably occurs as a result of an increase of free Max and thus in a more ecient formation of c-Myc-Max complexes. This is consistent with the ®nding that some cells from Mxi1 and Mad1 null animals have increased c-Myc activity as evidenced by an enhanced proliferative capacity and a greater tendency toward spontaneous or oncogene-mediated transformation (Foley et al., 1998; Schreiber-Agus et al., 1998) . In the case of Mad 1 null animals, increases in Mxi1 and Mad3 transcripts were also observed in the spleen, suggesting a compensatory and tissuespeci®c response to the disabling of Mad1 (Foley et al., 1998) .
To investigate in more detail the consequences of the functional`Mad null' phenotype created by Mmip-2/ Rnf-17 expression, we assessed the levels of transcripts of several Myc network components in neo and Mmip-2/Rnf-17 cells. As seen in Figure 3 , none of the cell lines examined contained detectable levels of Mad1 transcripts, which is consistent with the tendency for Mad1 expression to be con®ned to terminally dierentiating cells (Hurlin et al., 1995a; Henriksson and LuÈ scher, 1996) . In contrast Mxi1, Mad3 and Mad4 were all expressed, although the latter two were signi®cantly less abundant. Most notably, the levels of Mxi1 and Mad3 were increased 2 ± 4-fold in Mmip-2/Rnf-17 cells, whereas the level of Mad4 remained unchanged. Also of note were the reduced levels of cMyc transcripts in Mmip-2/Rnf-17 cells. Together, our results indicate that the molecular phenotype of Mmip-2/Rnf-17 cells is similar to that of certain Mad1 null cells. The lower levels of c-Myc in Mmip-2/Rnf-17 cells suggested that those expressing higher levels are at a growth disadvantage, perhaps due to a greater susceptibility to apoptotic death (see below).
Effects of Mmip-2/Rnf-17 on proliferation and apoptosis
The foregoing results, together with those reported previously (Yin et al., 1999a) , suggested that the inhibition of Mad protein function in Mmip-2/Rnf-17 cells, together with increased c-Myc functional activity, aected proliferation and/or apoptosis. We therefore compared the growth of neo and pooled Mmip-2/Rnf-17 cells supplemented with either 10 or 0.25% IL-3-conditioned medium. At the same time, the accumulation of apoptotic cells was monitored by trypan blue exclusion and con®rmed by TUNEL assay (Landay et al., 2000) . As seen in Figure 4a , under conditions of IL-3 excess (10% conditioned medium) neo and pooled Mmip-2/Rnf-17 cells grew at indistinguishable rates. Both cell lines also retained high viability (512% apoptotic cells) throughout the 7 day course of the experiment. In marked contrast, cells grown under limiting IL-3 concentrations (0.25% supplemented medium) showed signi®cant dierences in their growth rates and apoptotic pro®les (Figure 4b ). Under these 77 M DX for 48 h and were then fractionated into nuclear (N) and cytoplasmic (C) components. Twenty-®ve mg of each were then used in Western analysis for each of the proteins indicated to the right of the panels. For the detection of Mmip-2/Rnf-17, the anti-c-Myc epitope 9E10 monoclonal antibody was used conditions, Mmip-2/Rnf-17 cells grew at approximately one-fourth the rate of neo cells. This was accompanied by a nearly threefold increase in the rate of apoptosis in the former cell line. We thus conclude that, similar to what is seen when c-Myc is overexpressed, Mmip-2/ Rnf-17 cells are more prone to apoptosis when IL-3 concentrations are limiting.
We have shown that c-Myc overexpression sensitizes 32D cells to a variety of pro-apoptotic stimuli other than IL-3 deprivation (Nesbit et al., 1998 (Nesbit et al., , 2000 . To determine whether Mmip-2/Rnf-17 cells were similarly sensitive, we monitored apoptotic death in cl 15 and cl 16 cells following IL-3 withdrawal, or exposure to the cytotoxic agent Adriamycin, or the pro-apoptotic cytokine g-interferon (Nesbit et al., 1998 (Nesbit et al., , 2000 . The survival of these cells was compared to that of neo cells as well as to a 32D cell line transfected with a constitutively active c-Myc expression vector (`c-Myc cells') which we have previously shown displays a markedly pro-apoptotic phenotype (Nesbit et al., 1998 (Nesbit et al., , 2000 . Figure 5 shows that Mmip-2/Rnf-17 cells were as sensitive as c-Myc cells to all three apoptotic stimuli.
Expression of c-Myc target genes in Mmip-2/Rnf-17 cells
A number of genes which are direct targets for c-Myc have been characterized to date (Dang, 1999; Coller et al., 2000; O'Hagan et al., 2000) . Recently, we identi®ed a large number of additional c-Myc target genes in Mxi-1 and c-Myc blots were exposed for 18 h and 10 h, respectively, whereas Mad1, Mad3, and Mad4 blots were exposed for 72 h. A GAPDH blot to control for mRNA loading was exposed for 2 h. Phosphorimaging quantitation and normalization to GAPDH levels in triplicate experiments showed Mxi-1 levels to be increased an average of 1.5-fold in Mmip-2/Rnf-17 cells, Mad3 levels to be increased 2.8-fold, and c-Myc levels to be decreased 1.9-fold Figure 4 The growth of Mmip-2/Rnf-17 cells is compromised in limiting IL-3 concentrations. Neo (^, and light gray bars), pooled Mmip-2/Rnf-17 cells (&, and gray bars), cl. 15 (~, and white bars), and cl. 16 (*, and black bars) were grown in triplicate wells in 6 well plates containing medium supplemented with either 10% (a) or 0.25% IL-3-conditioned medium (b). Cells were plated at an initial density of 2610 4 /ml (total of 2 ml) with 490% viability in each case. Total cell counts (symbols) and the extent of cell death (bars) were determined daily. The values shown represent the average of triplicate experiments. Standard errors were 515% in all cases (not shown). On select days, aliquots were also subjected to TUNEL assays (Landay et al., 2000) . The per cent of apoptotic cells obtained by this method correlated well with those obtained by trypan blue exclusion 32D cells by the use of cDNA micro-arrays and, in many cases, con®rmed the dierentially expressed nature of their transcripts by Northern analysis (Nesbit et al., 2000) . Based on the foregoing observations of similar behaviors of c-Myc cells and Mmip-2/Rnf-17 cells, we predicted that the latter cell line would show deregulated expression of at least some c-Myc target genes. In order to test this, we ®rst measured the levels of endogenous ornithine decarboxylase (ODC) in several of our cell lines. The ODC gene is a direct transcriptional target for c-Myc and we have shown that the levels of endogenous ODC enzyme activity are oppositely regulated by c-Myc and Max (BelloFernandez et al., 1993; Zhang et al., 1997; Nesbit et al., 2000) . Figure 6 shows that, as previously demonstrated c-Myc cells contained nearly sixfold more ODC than neo cells. Pooled Mmip-2/Rnf-17 cells, as well as clones 15 and 16, also contained elevated levels of the enzyme. That the addition of DX did not result in higher enzyme levels suggested that, even in the absence of DX, the increased functional activity of c-Myc was already maximized (not shown).
We next used Northern blotting to examine the expression of some of the c-Myc target genes previously identi®ed in our cDNA microarray survey (Nesbit et al., 2000) . Neo cells or Mmip-2/Rnf-17 cl 15 and 16 cells, grown either in the absence or presence of DX, were used for this purpose. These studies revealed several distinct types of regulation (Figure 7) . First, several of the transcripts, most notably SM-20 and myeloperoxidase (MPO), were clearly up-regulated in cl 15 and 16 cells in much the same way as they are in c-Myc cells (Nesbit et al., 2000) . Similar to what had been observed with ODC (Figure 6 ), the presence of DX did not signi®cantly aect their expression. No signi®cant expression of these transcripts was seen in neo cells either in the absence or presence of DX. Second, transcripts encoding the Spi-2 protease inhibitor (Spi-2), which is also up-regulated by c-Myc, were also up-regulated in both Mmip-2/Rnf-17 clones and the addition of DX further augmented this Figure 6 Endogenous ODC enzyme levels in various 32D cell lines. Logarithmically growing cells from the indicated lines were plated into fresh IL-3-supplemented medium, cultured for an additional 48 h, and then assayed for endogenous ODC enzyme activity as previously described (Nesbit et al., 2000) . The results shown represent the average of three experiments, each performed in duplicate +1 s.e expression. Surprisingly, Spi-2 was also up-regulated by DX in neo cells. Third, the expressed sequence tag EST #421546, previously shown to be highly up-regulated by c-Myc, was not up-regulated in Mmip-2/Rnf-17 cells but was highly responsive to DX in all cases. Finally, EST #697416, a gene down-regulated by cMyc, was only weakly down-regulated in cl 15 and 16 in the absence of DX. However, a much more impressive degree of down-regulation was seen in DX-treated neo cells. An examination of several other up-and down-regulated transcripts such as ecm1, PF4, EST #444412, and EST#425279 (Nesbit et al., 2000) revealed no signi®cant regulation by either Mmip-2/Rnf-17 or DX (not shown). Taken together the results shown here and in Figure 6 indicate that Mmip-2/RNF-17, presumably as a result of its sequestration and inactivation of Mad proteins and the subsequent functional enhancement of c-Myc activity, is able to regulate some, but not all, c-Myc target genes.
Discussion
Previous work has demonstrated that the function of cMyc is ultimately dictated by interactions among other members of the Myc family of bHLH-ZIP transcriptional regulators (Blackwood et al., 1992; Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995a) . The ®rst such member to be identi®ed, Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) , is required for all known functions of c-Myc (Amati et al., 1993a,b; Amati and Land, 1994) . Members of the Mad family oppose c-Myc by competing for Max as well as for the same binding sites in c-Myc target genes (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995) . Transcriptional activation by c-Myc-Max complexes and transcriptional repression by Mad-Max complexes is associated with the recruitment of additional proteins which act through processes involving histone acetylation or deacetylation, respectively (Ayer et al., 1995; Schreiber-Agus et al., 1995; Alland et al., 1997; Laherty et al., 1997; McMahon et al., 2000) .
We previously identi®ed Mmip-2/Rnf-17 through a yeast two-hybrid approach using Mad1 as a bait (Yin et al., 1999) . Mmip-2/Rnf-17 interacts with and counteracts the repressive eects of all members of the Mad family on c-Myc-dependent processes such as transformation of primary ®broblasts in association with activated ras oncogenes. We have also shown in transient transfection assays that Mmip-1/Rnf-17 can reverse the transcriptional repression of Mad member proteins when tested with either a synthetic c-Mycresponsive promoter or with the ODC promoter, a natural c-Myc target (Bello-Fernandez et al., 1993) .
One of the most interesting aspects of Mmip-2/Rnf-17 is the means by which, when expressed in molar excess, it counters the repressive eects of Mad family members on transcription. This involves the translocation of Mad from its normal nuclear location to the cytoplasm, where it co-localizes with Mmip-2/Rnf-17 in large juxtanuclear`dots'. This is both a dynamic and reversible process, as the expression of Mad in molar excess to Mmip-2/Rnf-17 results in the re-distribution of the complex into the nucleus where the latter protein now assumes a diuse speckled pattern and co-localizes with Mad (Yin et al., 1999) . Subsequent to this ®nding, a similar role for the RING-®nger protein MDM-2, and its human ortholog HDM-2, in the redistribution of the p53 tumor suppressor protein from the nucleus to the cytoplasm, has been reported (Boyd et al., 2000; Geyer et al., 2000) .
In the current study, we have examined in more detail how Mmip-2/Rnf-17 aects the expression of members of the Myc network as well as the means by which Mmip-2/Rnf-17 modulates some of the cellular Figure 7 Expression of c-myc-regulated transcripts in Mmip-2/ Rnf-17 cells lines. Total RNAs were extracted from the indicated cell lines either prior to or after a 48 h exposure to 10 77 M DX. Five mg of each RNA were used for each of the Northern blots which were then hybridized with the indicated cDNA probes (Nesbit et al., 2000) . In the lower-most panel, the blot used to detect EST#421546 transcripts was stripped and re-hybridized with a GAPDH probe as a control for mRNA loading processes known aected by c-Myc. Cellular fractionation procedures con®rmed that stably expressed Mmip-2/Rnf-17 is normally a cytoplasmic protein and that it causes Mxi1, the most abundantly expressed member of the Mad family in 32D cells, to translocate from the nucleus into the cytoplasm. This is a speci®c process, as both c-Myc and Max remain con®ned to the nucleus. These observations reinforce the notion that the relative overexpression of Mmip-2/Rnf-17 results in a de facto`Mad null' state in which Mad family member proteins are rendered inactive by virtue of their recompartmentalization. This concept is further supported by the ®nding of a compensatory up-regulation of Mxi1 and Mad3 transcript levels reminiscent of that previously described in the spleens of Mad1-null mice (Foley et al., 1998) . In addition, the eects of Mmip-2/ Rnf-17 on proliferation and apoptosis are precisely those expected for cells which overexpress c-Myc. This includes a greater tendency for Mmip-2/Rnf-17 cells to undergo apoptotic death following such diverse insults as IL-3 withdrawal or exposure to cytotoxic chemicals or g-IFN (Figures 4 and 5) .
In previous work, we demonstrated that transient overexpression of Mmip-2/Rnf-17 could reverse the repressive eects of Mad proteins on an ODC promoter-CAT reporter plasmid (Yin et al., 1999a ). In the current work, the up-regulation of ODC in Mmip-2/Rnf-17 cells, as determined by measuring actual endogenous enzyme levels, was con®rmed ( Figure 6 ). Our recent identi®cation of a large number of additional c-Myc-regulated transcripts in 32D cells has also now provided us with the ability to assess how they are aected by the stable expression of Mmip-2/ Rnf-17. One ®nding that emerged from this analysis is that some of these target genes are indeed subject to the same regulation by Mmip-2/Rnf-17 as they are by c-Myc (Figure 7) . In contrast, a number of the genes show no such regulation by Mmip-2/Rnf-17, despite their being strongly regulated by c-Myc (Figure 7) . There are at least two possible, non-mutually exclusive, explanations for these observations. First, the level of functionally active c-Myc that is attained by its direct overexpression is probably higher than it is in Mmip-2/ Rnf-17 cells. To at least some degree, this may re¯ect the inability of constitutively expressed c-Myc to downregulate its own expression. In contrast, Mmip-2/Rnf-17 cells down-regulate expression of endogenous cMyc, presumably as a means of compensating for its pro-apoptotic activity (Figure 3) . Large dierences in c-Myc target gene transcript levels between neo cells and c-Myc cells may result from relatively modest dierences in c-Myc expression (Nesbit et al., 2000) . Thus, a more restricted subset of c-Myc target genes might be expected to be identi®ed in Mmip-2/Rnf-17 cells, as was indeed the case here. Second, the nuclear environment of c-Myc cells is likely to be signi®cantly dierent from that of Mmip-2/Rnf-17 cells. In the former case, Mad proteins, localized to the nucleus, will be released from their association with Max and rendered free to interact with other bHLH-ZIP and non-bHLH-ZIP Mad-associating proteins such as Mlx and Mmip-1 (Gupta et al., 1998; Billin et al., 1999; Meroni et al., 2000) . The association between Max and its other, non-Mad, partner proteins such as Mnt and Mga should also be reduced by the quantitative increase in c-Myc (Hurlin et al., 1997 (Hurlin et al., , 1999 . The abundance of complexes between c-Myc and the various proteins which interact with its TAD (Facchini and Penn, 1998; Sakamuro and Prendergast, 1999) would also change in a manner that, under the simplest of conditions, mirrored their relative abundance. In contrast, Mmip-2/Rnf-17 overexpression would deplete the nucleus of Mad proteins leaving Mlx, Mmip-1, and presumably other Mad-interacting proteins either free to interact with as yet unidenti®ed nuclear partners. The ratios of Mnt-Max and Mga-Max, compared to cMyc-Max complexes, should be less aected than in cMyc cells since the absolute levels of c-Myc would remain little changed. For the same reason, the relative ratios of complexes between c-Myc and its TADinteracting proteins should be less aected than in cMyc cells. Finally, we cannot eliminate the possibility that Mmip-2/Rnf-17 regulates gene expression and cMyc-like phenotypes through non-Myc network pathways.
Irrespective of the extent to which Mmip-2/Rnf-17 and c-Myc vary in their regulation c-Myc target genes, it is clear that the phenotypic consequences may, in at least some cases, be remarkably similar (Figures 4 and  5 ). This suggests that only a subset of genetic targets, subject to regulation by both c-Myc and Mmip-2/Rnf-17, may be sucient to modulate the eects on growth and apoptosis described here. This is certainly consistent with previous ®ndings that a number of cMyc targets are, by themselves, capable of imparting certain c-myc phenotypes such as apoptosis and transformation (Dang, 1999) . However, this similarity does not apply in all situations and dierent subsets of targets are likely to orchestrate dierent phenotypes. For example, unlike c-Myc, Mmip-2/Rnf-17 is unable to promote tetraploidy in 32D cells either when passage through M-phase is inhibited by mitotic spindle poisons, or when p53 is inactivated (Yin et al., 1999b and X-YY and EVP, unpublished observations) .
Perhaps the most surprising ®nding to emerge from this study was that several of the transcripts, previously identi®ed as being c-Myc targets, are also regulated by DX. In retrospect, this is not entirely unexpected, given that c-Myc and GCs in¯uence several of the same cellular processes, although often in opposite ways. For example, c-Myc is necessary for cells to enter into and remain in the cell cycle (Obaya et al., 1999) . Constitutive c-Myc expression also generally blocks terminal dierentiation, probably by preventing the cell cycle withdrawal that invariably accompanies this process (Coppola and Cole, 1986; Prochownik and Kukowska, 1986) . c-Myc overexpression also sensitizes cells to a wide variety of pro-apoptotic stimuli (Askew et al., 1991; Evan et al., 1992; Nesbit et al., 1998 Nesbit et al., , 2000 . GCs generally block proliferation, enhance dierentiation and promote apoptosis (Longenecker et al., 1984; Beato et al., 1995; MacDougald and Lane, 1995) . In the case of lymphoid cells, where the eects of GCs on proliferation and apoptosis are particularly pronounced, a marked reduction in c-Myc levels is associated with GC-induced G 0 arrest which can be overcome by the enforced expression of c-Myc (Forsthoefel and Thompson, 1987; Thulasi et al., 1993; Rhee et al., 1995) . On the other hand GCs, like c-Myc, can enhance proliferation and inhibit dierentiation in certain hematopoietic systems (Golde et al., 1976; Scher et al., 1978; von Lindern et al., 1999) . Other cellular functions which can be in¯uenced by both c-Myc and GCs include those pertaining to carbohydrate metabolism, the synthesis of extracellular matrix and adhesion molecules, the regulation of components of major histocompatibility loci, and the production of and sensitivity to interferons (Cato and Wade, 1996) . Over 50 c-Myc regulated genes and an even larger number of GC-regulated genes have now been identi®ed by a variety of methods (Geley et al., 1996; Dang, 1999; Coller et al., 2000; Nesbit et al., 2000; O'Hagan et al., 2000) . Among the common targets are those for collagen, integrins, ODC, protein kinase C, and b-galactoside binding protein, as well as c-Myc itself. These observations suggest a model for gene regulation by c-Myc and GCs in which they modulate distinct but overlapping subsets of transcripts (Figure 8 ). Examples of genes regulated by c-Myc but not by GCs include SM-20 and MPO (Figure 7 ) whereas those regulated by both c-Myc and GCs include Spi-2 protease inhibitor, EST#421546 and EST697416. The seemingly paradoxical ®nding that GCs down-regulate c-Myc, yet induce apoptosis in a cMyc-dependent manner in some systems (Thompson, 1998) , might be explained by assuming that the overlap of c-myc-and GC-regulated genes includes some which play particularly important roles in apoptosis.
In summary, the work presented here has shown that Mmip-2/Rnf-17 is a general inhibitor of Mad family member function. This occurs as a result of the translocation of Mad-Mmip-2/Rnf-17 complexes from the nucleus to the cytoplasm where they are prevented from interacting with Max. The consequent functional increase in c-Myc results in an enhanced cellular sensitivity to several mechanistically diverse apoptotic stimuli. The extent of the resultant cell death is indistinguishable from that seen with enforced c-Myc expression. At the molecular level, expression of Mmip-2/Rnf-17 is associated with the regulation of some of the genes which have been previously identi®ed as being c-Myc targets. An unanticipated observation was that some Mmip-2/Rnf-17 and c-Mycresponsive genes are also regulated in response to GCs. This indicates a previously unrecognized association between c-Myc and GCs and identi®es potential molecular candidates which mediate their related eects.
Materials and methods
Construction of a conditional Mmip-2/Rnf-17 expression vector
The coding region of the 316 amino acid Mmip-2/Rnf-17 cDNA (Yin et al., 1999b) was ampli®ed by conventional PCR using the following oligonucleotide primers: forward: 5'-CGC CTC GAG ACA ATG GCG GCA GAG GCT TCG-3'; reverse: 5'-CGC CTC GAG TCC ATC TTC ATT TTC TAG AGG G-3', where italicized bases denote engineered`GC clamps' and XhoI sites. In the ®rst case, the underlined triplet denotes the start of translation, whereas in the second case, it indicates the reverse complement of the translational stop site (TGA). Following digestion with XhoI, the PCR product was puri®ed on a 1% agarose gel and ligated into the XhoI site of pMSGneo-MT vector downstream of the glucocorticoidinducible MMTV promoter (Amersham, Piscataway, NJ, USA) and in frame with the coding region of the c-myc epitope recognized by the 9E10 monoclonal antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). The ®nal construct, hereafter referred to as pMSGneoMT-Mmip-2/ Rnf-17, was identi®ed by restriction mapping and DNA sequencing which con®rmed that the amino terminus of Mmip-2/Rnf-17 was fused in-frame with the c-Myc epitope.
Selection and propagation of Mmip-2/Rnf-17 transfectants 32Dcl3 cells (hereafter referred to as 32D cells) were maintained as previously described in RPMI medium (GIBCO ± BRL, Grand Island, NY, USA) supplemented with 10% fetal calf serum (GIBCO ± BRL) and 10% conditioned medium from interleukin-3 (IL-3)-producing WEHI-3B cells (Nesbit et al., 1998) . For stable expression, pMSGneoMTMmip-2/Rnf-17 plasmid DNA or control pMSGneoMT vector DNA was puri®ed on Qiagen columns (Qiagen, Chatsworth, CA, USA). Five mg of each PvuI-linearized plasmid DNA was transfected by electroporation into 2610 7 32D cells and selected in a ®nal concentration of 500 mg/ml G-418 (GIBCO ± BRL) as previously described (Nesbit et al., 1998) . Pooled, G-418-resistant clones, as well as two 
Northern and Western blotting
Total RNAs were extracted as previously described (Smith et al., 1990) . Five mg of each sample were resolved in 1% agarose-formaldehyde gels, blotted to Nytran membranes (Schleicher & Schuell, Keane, NH, USA) and hybridized with the indicated 32 P-labeled cDNA probes (sp. act. 43610 8 d.p.m./mg; Nesbit et al., 2000) in Ultrahyb Solution (Ambion, Austin, TX, USA) according to the directions of the supplier. Blots were exposed to Kodak BioMax MS ®lm on a BioMax MS intensifying screen for 4 ± 48 h depending on the probe. All cDNA probes for Myc network proteins consisted of PCR fragments encompassing the entire coding region of the indicated transcripts. cDNA probes for c-Mycregulated genes ( Figure 7) were obtained by isolating the inserts from their parental plasmids on 1% agarose gels. Plasmids were obtained from Genome Systems (St. Louis, MO, USA) and sequenced from both ends to con®rm the identity of the inserts.
Western blotting was performed as previously described (Nesbit et al., 1998) . Brie¯y, 25 mg of total cellular extract was resolved on either 10 or 12% SDS-polyacrylamide gels and electroblotted to PVDF membranes (Millipore, Bedford, NY, USA). For some experiments, cells were ®rst fractionated in nuclear and cytoplasmic compartments. This was done by pelleting approximately 5610 7 cells by low-speed centrifugation, followed by two washes in phosphate-buered saline, and a ®nal wash in ice-cold hypotonic buer (10 mM Tris-Hcl, pH 7.4; 10 mM NaCl; 5 mM MgCl 2 ). The ®nal pellet was resuspended in hypotonic buer containing 0.15% Nonidet-P40 (Sigma) plus a protease inhibitor cocktail (Boehringer-Mannheim, Indianapolis, IN, USA) and incubated on ice for 5 min. Cytoplasmic lysis was monitored continuously by phase-contrast microscopy. Puri®ed nuclei were then pelleted at 1500 g. The supernatent was removed and saved. Nuclei were washed one additional time with the same buer, pelleted and the supernatent combined with the ®rst cytoplasmic fraction. 56 SDS ± PAGE buer was added to a ®nal concentration of 16 followed by brief sonication of the nuclear sample to reduce viscosity. The samples were then boiled for 5 min prior to SDS ± PAGE. Rabbit polyclonal antibodies included anti-c-Myc, raised against the bHLH-ZIP domain of the recombinant murine protein (Prochownik and VanAntwerp, 1993) ; anti-human Max, prepared against the full-length, 160 amino acid isoform (Zhang et al., 1997) ; anti human Mad1 and Mxi1, prepared against the full-length proteins (Gupta et al., 1998; Yin et al., 1999) ; anti-Mad3, prepared against the full-length murine protein (#sc770, Santa Cruz); and anti-Mad4 prepared against the full-length murine protein (sc771, Santa Cruz). Anti-PARP antibody (#sc1562) and anti-Bcl-2 antibody (#sc-492) were used in control experiments to detect proteins known to be con®ned to the nuclear and cytoplasmic (mitochondrial) fractions, respectively. A monoclonal antibody (sc8432, Santa Cruz) broadly reactive against b-actin, was used to normalize for protein concentrations. All primary antibodies were used at concentrations ranging from 1 : 500 ± 1 : 2000 as determined empirically. Blocking and primary antibody incubations were performed at room temperature in PBS containing 5% nonfat dry milk and 0.1% Tween-20 (Sigma) (PBS-T-milk) for 2 h. After extensive washing in PBS-T alone, blots were again incubated with the appropriate horseradish peroxidaseconjugated secondary antibody (1 : 1000: Santa Cruz) in PBS-T-milk for 1 h, washed in PBS-T, and developed using a Renaissance enhanced chemiluminescence kit (New England Nuclear, Boston, MA, USA).
Ornithine decarboxylase (ODC) assays
Assays were performed as previously described (Nesbit et al., 1998) .
Growth and apoptosis assays
Standard growth curves were performed as previously described in medium supplemented with either 10 or 0.25% IL-3-conditioned medium (Zhang et al., 1997) . Cells were plated at an initial concentration of 2610 4 /ml and manual counts were performed daily with a hemacytometer. Dead cells were identi®ed by trypan blue exclusion which correlates well with actual apoptosis as measured with either the TUNEL assay or by the presence of cells with subdiploid DNA content as determined by¯ow cytometric analysis of propidium iodide-stained nuclei (Landay et al., 2000) . Apoptosis assays were performed by plating cells into fresh medium lacking IL-3 or into medium supplemented with 10% IL-3-conditioned medium and containing either 125 nM Adriamycin (ADR, Sigma); or 100 ng/ml of recombinant rat gamma interferon (g-IFN, R&D Systems, Minneapolis, MN, USA).
